 |
Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- 12/22/2021
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...
12/20/2021FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...
11/18/2021New offering automates previously manual supply tasks, enabling clinical lab staff to focus on patient careCardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...
11/16/2021Operation will deliver healthcare supplies on-demand to pharmacies, helping mitigate risk of stock-outs and improving accessKannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...
-
11/09/2021- Revenue increased 13% to $44.0 billion
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...
-
11/04/2021
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...
10/28/2021Cardinal Health will explore how to better standardize real world evidence for use in regulatory decisionsCardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...
10/26/2021Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...
10/14/2021Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...